Ritonavir
Study: Antiviral drugs reduce Covid death risk
The use of antiviral medications significantly lowers the risk of hospitalization and death caused by Covid-19 among older patients, according to a Greek study.
- Read more about Study: Antiviral drugs reduce Covid death risk
- Log in to post comments
WHO recommends the Pfizer Pill against COVID-19
The World Health Organization said yesterday that it "strongly recommends" Pfizer Paxlovid's antiviral pill against Covid-19 for patients with milder forms of the disease who are still at high risk of hospitalization.
- Read more about WHO recommends the Pfizer Pill against COVID-19
- Log in to post comments
Prof. Ilko Getov: Bulgarians will have Access to Anti-Covid Drugs in Tablet Form
Breakthrough in drugs against COVID-19 by oral administration, in tablet form. At this stage we have two such molecules - one is molnupiravir, the other ritonavir. This was commented in "The day begins" Prof. Ilko Getov, Bulgarian representative in the European Medicines Agency.
Clinical trials have been conducted that show the drugs have excellent efficacy, he said.
Pfizer has Announced a Promising Treatment with Pills against COVID-19
Tests of experimental antiviral treatment against COVID-19 by the American company "Pfizer" (Pfizer) in the form of a pill have proved so promising that they have been shortened. The reason is that it reduced by 89% the risk of hospitalization or death in adults at risk of developing a severe form of the disease.
Pfizer starts Testing Covid Prevention Pill
Pfizer announced today it has started a mid-to-late-stage study testing its oral antiviral drug for the prevention of Covid-19 infection among those who have been exposed to the virus, news wires reported. The company and its rivals, such as US-based Merck and Swiss Roche, have been racing to develop the first antiviral pill for Covid-19.
- Read more about Pfizer starts Testing Covid Prevention Pill
- Log in to post comments